Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

1,125.00p
   
  • Change Today:
      5.50p
  • 52 Week High: 1,208.50p
  • 52 Week Low: 917.60p
  • Currency: UK Pounds
  • Shares Issued: 875.96m
  • Volume: 1,216,811
  • Market Cap: £9,854m
  • RiskGrade: 173

Smith & Nephew secures US DOD contract worth up to $75m

By Michele Maatouk

Date: Tuesday 27 May 2025

LONDON (ShareCast) - (Sharecast News) - Smith & Nephew said on Tuesday that it has been awarded a contract worth up to $75m to provide Negative Pressure Wound Therapy systems to the US Department of Defense.
The company has been selected to provide its Renasys Touch Negative Pressure Wound Therapy (NPWT) Systems under a single award, 10-year contract through the Defense Logistics Agency (DLA).

It said the system will support military medical providers to administer therapy through prolonged casualty care, first surgical intervention, aeromedical transport and definitive care in military treatment facilities. Renasys Touch NPWT is manufactured in the US.

Dennis Lyons, Sr. Director Military & Federal Health for Smith & Nephew, said: "Future conflicts will be more difficult and complex. This implies medical devices and treatments will need to be simplified and more intuitive to be used farther forward by a wide range of providers.

"Renasys Touch NPWT will provide that simplified negative pressure wound therapy solution to the military care continuum for warfighters who need it most."

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price 1,125.00p
Change Today 5.50p
% Change 0.49 %
52 Week High 1,208.50p
52 Week Low 917.60p
Volume 1,216,811
Shares Issued 875.96m
Market Cap £9,854m
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
88.59% below the market average88.59% below the market average88.59% below the market average88.59% below the market average88.59% below the market average
9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average9.09% below the sector average
Price Trend
23.14% above the market average23.14% above the market average23.14% above the market average23.14% above the market average23.14% above the market average
48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average48.57% above the sector average
Income
34.62% below the market average34.62% below the market average34.62% below the market average34.62% below the market average34.62% below the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
11.08% above the market average11.08% above the market average11.08% above the market average11.08% above the market average11.08% above the market average
77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 9
Sell 0
Strong Sell 0
Total 16
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Final Interim
Ex-Div 27-Mar-25 03-Oct-24
Paid 28-May-25 08-Nov-24
Amount 23.10¢ 14.40¢

Trades for 18-Jul-2025

Time Volume / Share Price
16:35 600 @ 1,125.00p
16:35 1,400 @ 1,125.00p
16:35 3,910 @ 1,125.00p
16:35 463 @ 1,125.00p
16:35 1,093 @ 1,125.00p

Smith and Nephew Key Personnel

CEO Deepak Nath
CFO John Rogers

Top of Page